Jennifer Levy is the Scientific Director at Coalition to Cure Calpain 3 (C3), where she spearheads the organization’s mission to develop effective treatments for calpainopathies (limb-girdle muscular dystrophy types 2A/R1 and D4) by overseeing the research grant program. Managing a diverse research portfolio spanning discovery through trial readiness, she has directed over $3 million in funding toward high-impact projects. Dr. Levy is the principal investigator of the LGMD2A/Calpainopathy Registry, an essential data initiative leveraging the insights of 350+ participants to better understand the patient experience. Additionally, she collaborates with key leaders in academia, industry, government, and nonprofit organizations to drive progress towards shared goals. Dr. Levy earned her PhD from the University of Pennsylvania and completed her postdoctoral fellowship in Kevin Campbell’s laboratory at the Howard Hughes Medical Institute and the University of Iowa. She co-authored multiple peer-reviewed manuscripts, and her research was supported by an NIH training grant and a Muscular Dystrophy Association development grant.